Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 3
2011 3
2012 1
2013 3
2014 1
2015 2
2017 4
2018 8
2019 9
2020 19
2021 13
2022 15
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Sweat allergy.
Takahagi S, Tanaka A, Hide M. Takahagi S, et al. Allergol Int. 2018 Oct;67(4):435-441. doi: 10.1016/j.alit.2018.07.002. Epub 2018 Jul 31. Allergol Int. 2018. PMID: 30075993 Free article. Review.
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
Maurer M, Ensina LF, Gimenez-Arnau AM, Sussman G, Hide M, Saini S, Grattan C, Fomina D, Rigopoulos D, Berard F, Canonica GW, Rockmann H, Irani C, Szepietowski JC, Leflein J, Bernstein JA, Peter JG, Kulthanan K, Godse K, Ardusso L, Ukhanova O, Staubach P, Sinclair R, Gogate S, Thomsen SF, Tanus T, Ye YM, Burciu A, Barve A, Modi D, Scosyrev E, Hua E, Letzelter K, Varanasi V, Patekar M, Severin T; PEARL-1 and PEARL-2 trial investigators. Maurer M, et al. Lancet. 2024 Jan 13;403(10422):147-159. doi: 10.1016/S0140-6736(23)01684-7. Epub 2023 Nov 23. Lancet. 2024. PMID: 38008109 Clinical Trial.
Roles of omalizumab in various allergic diseases.
Okayama Y, Matsumoto H, Odajima H, Takahagi S, Hide M, Okubo K. Okayama Y, et al. Among authors: takahagi s. Allergol Int. 2020 Apr;69(2):167-177. doi: 10.1016/j.alit.2020.01.004. Epub 2020 Feb 14. Allergol Int. 2020. PMID: 32067933 Free article. Review.
Case of anaphylaxis to maltose solution.
Moriwaki M, Umeda N, Ishii K, Morikawa H, Takahagi S, Hide M. Moriwaki M, et al. Among authors: takahagi s. J Dermatol. 2020 Apr;47(4):e107-e108. doi: 10.1111/1346-8138.15263. Epub 2020 Feb 13. J Dermatol. 2020. PMID: 32056257 No abstract available.
74 results